Research · Sep 3, 2026
[MKSI] MKS Instruments Thesis 2026: Atotech Integration Drives Semiconductor Plus Photonics Recovery
MKS Inc. (NASDAQ: MKSI; previously MKS Instruments through October 2024) FY2025 revenue ~$3.7-4.0B (+5-10%) with adj. EPS ~$7.10-7.85 reflecting continued post-2024 Semiconductor (~$1.7-1.9B; +5-10%) WFE recovery + selected post-2024 Electronics & Packaging (~$1.0-1.1B; +0-3%) Atotech integrated PCB chemistry + selected post-2024 Specialty Industrial (~$0.9-1.0B; +5-8%) photonics + life sciences + research recovery + selected post-August 2022 ~$5.1B aggregate Atotech BV acquisition integration optimization under continued President + CEO John T.C. Lee (~5-year tenure since June 2020). Global provider of selected various technologies for selected major semiconductor + electronics + selected industrial customers. Founded 1961 as MKS Instruments Inc. by John R. Bertucci in Burlington Massachusetts (~64-year heritage); selected post-1999 NASDAQ listing IPO; selected post-2016 ~$980M Newport Corporation; selected post-2018 ~$985M Electro Scientific Industries; selected post-August 2022 ~$5.1B Atotech BV acquisition; selected post-October 2024 MKS Instruments → MKS Inc. rebrand. Headquartered in Andover Massachusetts; ~9,500+ employees globally with ~$3.7-4.0B revenue. Three primary business segments: Semiconductor (~45% revenue ~$1.7-1.9B), Electronics & Packaging (~28% ~$1.0-1.1B), Specialty Industrial (~25% ~$0.9-1.0B). Semiconductor WFE cycle recovery: ~$1.7-1.9B FY2025 (+5-10% YoY); selected major Applied Materials + Lam Research + KLA + ASML WFE customers; selected continued post-2024 selected post-FY2024 trough WFE cyclical recovery; selected post-2024 leading-edge logic + DRAM semiconductor capex cycle. Atotech integration cycle: post-August 2022 ~$5.1B aggregate Atotech BV (selected chemical specialty supplier covering PCB chemistry + general metal finishing); selected continued post-2024 integration cost synergies + commercial cross-sell; ~28% Electronics & Packaging revenue mix. Specialty Industrial photonics + life sciences: photonics + lasers + life sciences + research; selected continued post-2024 cyclical recovery. President + CEO John T.C. Lee since June 2020 (~5-year tenure); CFO Ram Mayampurath. Capital structure: ~$0.7-0.9B cash + investments; ~$0.88 annual dividend FY2025 (~+0% growth — Atotech deleveraging priority); modest buybacks; net leverage ~3.5-4.0x (post-Atotech deleveraging); investment-grade Ba2/BB credit rating. FY2026 thesis: Atotech integration cycle + Semiconductor WFE recovery + Specialty Industrial photonics + life sciences + post-Atotech deleveraging + selected potential post-deleveraging capital return acceleration. Risks: WFE cycle sustainability, Atotech integration execution, Advanced Energy + Brooks Automation competition, Top 5 WFE customer concentration, USD/EUR + USD/CNY currency volatility.